Suberoylanilide hydroxamic acid, an inhibitor of histone deacetylase, suppresses vasculogenic mimicry and proliferation of highly aggressive pancreatic cancer PaTu8988 cells

Overview of attention for article published in BMC Cancer, May 2014

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (72nd percentile)

Mentioned by

twitter: 1 tweeter
patent: 1 patent

peer_reviews: 1 peer review site

Citations

dimensions_citation: 18 Dimensions

Readers on

mendeley: 13 Mendeley

Summary Twitter Patents Peer reviews Dimensions citations

So far, Dimensions has found 18 publications that cite this research output.

18

The most recent citing publications are shown below. View all 18 publications that cite this research output on Dimensions.

Clinical significance of vasculogenic mimicry, vascular endothelial cadherin and SOX4 in patients with esophageal squamous cell carcinoma.

Article in International Journal of Clinical and Experimental Pathology (July 2019)

Class I histone deacetylase inhibitor suppresses vasculogenic mimicry by enhancing the expression of tumor suppressor and anti-angiogenesis genes in aggressive human TNBC cells

Article in International Journal of Oncology (May 2019)

Vasculogenic mimicry dominated by tumors and migration and invasion of carcinomas

Article in International Journal of Surgery (January 2019)